211 related articles for article (PubMed ID: 24891166)
1. Molecular diagnostics for thyroid nodules: the current state of affairs.
Mon SY; Hodak SP
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):345-65. PubMed ID: 24891166
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
[TBL] [Abstract][Full Text] [Related]
3. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
[TBL] [Abstract][Full Text] [Related]
4. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
[TBL] [Abstract][Full Text] [Related]
5. Molecular Testing of Thyroid Nodules: A Review of Current Available Tests for Fine-Needle Aspiration Specimens.
Zhang M; Lin O
Arch Pathol Lab Med; 2016 Dec; 140(12):1338-1344. PubMed ID: 27557410
[TBL] [Abstract][Full Text] [Related]
6. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
7. Role of Ancillary Techniques in Thyroid Cytology Specimens.
Nishino M; Krane JF
Acta Cytol; 2020; 64(1-2):40-51. PubMed ID: 30947167
[TBL] [Abstract][Full Text] [Related]
8. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Nikiforov YE; Ohori NP; Hodak SP; Carty SE; LeBeau SO; Ferris RL; Yip L; Seethala RR; Tublin ME; Stang MT; Coyne C; Johnson JT; Stewart AF; Nikiforova MN
J Clin Endocrinol Metab; 2011 Nov; 96(11):3390-7. PubMed ID: 21880806
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
10. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.
Ferraz C; Eszlinger M; Paschke R
J Clin Endocrinol Metab; 2011 Jul; 96(7):2016-26. PubMed ID: 21593119
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.
Bhatia P; Deniwar A; Friedlander P; Aslam R; Kandil E
Anticancer Res; 2015 Mar; 35(3):1237-41. PubMed ID: 25750270
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostic testing and the indeterminate thyroid nodule.
Yip L
Curr Opin Oncol; 2014 Jan; 26(1):8-13. PubMed ID: 24225416
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnostic gene expression thyroid testing.
Steward DL; Kloos RT
Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
[TBL] [Abstract][Full Text] [Related]
15. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers.
Nikiforov YE; Yip L; Nikiforova MN
Clin Cancer Res; 2013 May; 19(9):2283-8. PubMed ID: 23422095
[TBL] [Abstract][Full Text] [Related]
16. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
Eszlinger M; Hegedüs L; Paschke R
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
[TBL] [Abstract][Full Text] [Related]
17. Local molecular analysis of indeterminate thyroid nodules.
Gill MS; Nayan S; Kocovski L; Cutz JC; Archibald SD; Jackson BS; Young JE; Gupta MK
J Otolaryngol Head Neck Surg; 2015 Dec; 44():52. PubMed ID: 26621130
[TBL] [Abstract][Full Text] [Related]
18. Molecular testing for thyroid nodules: Review and current state.
Roth MY; Witt RL; Steward DL
Cancer; 2018 Mar; 124(5):888-898. PubMed ID: 29278433
[TBL] [Abstract][Full Text] [Related]
19. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
20. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.
Carpi A; Nicolini A; Gross MD; Fig LM; Shapiro B; Fanti S; Rampin L; Polico C; Rubello D
Biomed Pharmacother; 2005 Oct; 59(9):517-20. PubMed ID: 16202555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
